Clinical Trial Update: Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial evaluates allogeneic hematopoietic stem cell transplantation using G-CSF mobilized CD34+ selected cells co-infused with a reduced-do…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia
• Myelodysplastic Syndrome

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Severe Aplastic Anemia, MDS (Myelodysplastic Syndrome) | Phase 2 | Status: RECRUITING